1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends


  • May 2015
  • -
  • Expernova
  • -
  • 141 pages

Find in this report 30 profiles of innovative companies that are part of the expertise on Oncology, in North America.

Cancer is a pathology characterized by uncontrolled and cellular proliferation which causes the death of millions of people worldwide every year. Lifestyles, aging, population growth and rising treatment costs, are new challenges for the fight against cancer. Lifestyle (diet and smoking), exposure to carcinogens, and hereditary factors are the main causes of cancer, amongst which the most commonly diagnosed are lung, breast, and colorectal cancer.
With almost 22 million new annual cases expected in 2030, it is essential that the domain of oncology evolves and develops. The needs of patients in oncology change requiring this special branch of medical study, diagnostic and therapeutic management to reflect on new diagnostic and therapeutic approaches. Thanks to promising, innovative treatments and new therapies, we are already observing undeniable advances which have a real impact on the chances of survival.
The experts in oncology are looking toward a future focused on personalized medicine, out-patient care and successful methods of cured patients. The development of techniques for mini or non-invasive procedures and high-definition scanners dedicated to patients, are also major topics for future development.

Featuring 30 companies’ profiles such as Abbott Laboratories and Pfizer, this report is ideal for anyone wanting:

- Identify R&D Partners,

- Obtain IP & Technologic Intelligence,

- Develop your R&D Partnerships,

- And also benchmark competitors.

…all on a global scale.

These Key Innovation Leaders are based across in North America (USA, Canada…).

For each of them, you will receive a scientific profile updated at time of order, a selection of focused works and a presentation of their collaborative partners, as well as an in-depth explanation of why they are leaders on Oncology.

Here are some examples of our data sources:

Research institutes databases (NASA, MIT, Fraunhofer, ...)

Patent Databases (European Patent Office, USPTO, ...)

Thematic Databases (MedLine/PubMed, INRA, ...)

Project Databases (Cordis FP-7, FP-6, ...)

Profile packs are generated and updated with the unique mapping technology developed by Expernova. Expernova data base is constantly growing, so each profile pack updated at any given time is potentially different from the others profile packs generated at other times on the same subject.


medical oncology, radiation oncology, pharmaceutical composition, clinical trial, malignant tumor, pediatric oncology, cancer, radiation therapy, antineoplastic agent, oncological disease, oncology nursing, gynecologic oncology

Table Of Contents


I. Selection of key-profiles of innovative companies

1. Companies profiles


- Companies Index

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 10 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6 995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Ovarian Cancer: Analytical Tool

August 2016 $ 7 125


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.